WellCare reaches $137.5 million civil FCA settlement; WellPoint jumps into comparative-effectiveness fray;

> WellCare Health Plans in Tampa, Fla., has reached a preliminary deal with the civil divisions of the U.S. Department of Justice and the U.S. Attorney's Offices for the Middle District of Florida and Connecticut to settle False Claims Act allegations of accounting fraud to a Securities and Exchange Commission (SEC) filing. The price tag to end the investigations that have been haunting the Medicare and Medicaid health insurer since October 2007: $137.5 million. FierceHealthPayer

> Based on a review of 26,000 members on the osteoporosis drugs Boniva, Actonel and Fosamax, WellPoint now requires that members try Sanofi-Aventis' Actonel or Merck's Fosamax before it will pay for the Roche/GlaxoSmithKline drug Boniva. FiercePharma

> Hospital Impact contributor Thomas Dahlborg knows all too well about how money in healthcare is oftentimes based more on quantity than quality. In his latest post, he wonders what would happen if Medicare started reimbursing based on the improving status of a health community. Post

And Finally... If two hunters wearing camouflage get married in a tree in the woods in Iowa, can anybody see it? Article